• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化学修饰核酸与稳定素-2清除受体相互作用的结构决定因素

Structural Determinants for the Interactions of Chemically Modified Nucleic Acids with the Stabilin-2 Clearance Receptor.

作者信息

Gaus Hans, Miller Colton M, Seth Punit P, Harris Edward N

机构信息

Department of Medicinal Chemistry , Ionis Pharmaceuticals , Carlsbad , California 92010 , United States.

Department of Biochemistry , University of Nebraska , Lincoln , Nebraska 68588 , United States.

出版信息

Biochemistry. 2018 Apr 10;57(14):2061-2064. doi: 10.1021/acs.biochem.8b00126. Epub 2018 Mar 30.

DOI:10.1021/acs.biochem.8b00126
PMID:29589907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5905987/
Abstract

The Stabilin receptors are systemic clearance receptors for some classes of chemically modified nucleic acid therapeutics. In this study, the recombinant human secreted ecto-domain of the small isoform of Stabilin-2 (s190) was purified from cell culture and evaluated for direct binding with a multitude of antisense oligonucleotides (ASOs) using a fluorescence polarization-based assay. The tested ASOs varied in their backbone composition, modification of the ribose 2' position, overall length of the oligo, and sequence of the nucleotide bases. A fully phosphorothioate (PS) ASO with a 5-10-5 pattern of flanking 2'- O-methoxyethyl modifications was then used to test the effects of pH and salt concentration on receptor binding. These tests concluded that the PS backbone was the primary determinant for ASO binding and that decreasing pH and increasing salt generally increased the rate of ligand dissociation and fit within the biological parameters expected of a constitutive recycling receptor. These results will be useful in the rational design of therapeutic oligonucleotides for enhancing their affinity or avoidance of the Stabilin receptors.

摘要

Stabilin受体是某些化学修饰核酸治疗剂的全身清除受体。在本研究中,从细胞培养物中纯化了重组人分泌型Stabilin-2小异构体的胞外域(s190),并使用基于荧光偏振的测定法评估其与多种反义寡核苷酸(ASO)的直接结合。所测试的ASO在其骨架组成、核糖2'位修饰、寡核苷酸的全长和核苷酸碱基序列方面各不相同。然后使用具有5-10-5模式的侧翼2'-O-甲氧基乙基修饰的全硫代磷酸酯(PS)ASO来测试pH和盐浓度对受体结合的影响。这些测试得出结论,PS骨架是ASO结合的主要决定因素,降低pH和增加盐浓度通常会增加配体解离速率,并且符合组成型循环受体预期的生物学参数。这些结果将有助于合理设计治疗性寡核苷酸,以增强其对Stabilin受体的亲和力或避免与该受体结合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f52/5905987/aee7fb0879f8/bi-2018-00126e_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f52/5905987/006ad3b715cc/bi-2018-00126e_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f52/5905987/b769d33457ea/bi-2018-00126e_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f52/5905987/aee7fb0879f8/bi-2018-00126e_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f52/5905987/006ad3b715cc/bi-2018-00126e_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f52/5905987/b769d33457ea/bi-2018-00126e_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f52/5905987/aee7fb0879f8/bi-2018-00126e_0003.jpg

相似文献

1
Structural Determinants for the Interactions of Chemically Modified Nucleic Acids with the Stabilin-2 Clearance Receptor.化学修饰核酸与稳定素-2清除受体相互作用的结构决定因素
Biochemistry. 2018 Apr 10;57(14):2061-2064. doi: 10.1021/acs.biochem.8b00126. Epub 2018 Mar 30.
2
Stabilin-1 and Stabilin-2 are specific receptors for the cellular internalization of phosphorothioate-modified antisense oligonucleotides (ASOs) in the liver.Stabilin-1和Stabilin-2是硫代磷酸酯修饰的反义寡核苷酸(ASO)在肝脏中进行细胞内化的特异性受体。
Nucleic Acids Res. 2016 Apr 7;44(6):2782-94. doi: 10.1093/nar/gkw112. Epub 2016 Feb 22.
3
Characterization of the interactions of chemically-modified therapeutic nucleic acids with plasma proteins using a fluorescence polarization assay.采用荧光偏振测定法研究化学修饰治疗性核酸与血浆蛋白的相互作用。
Nucleic Acids Res. 2019 Feb 20;47(3):1110-1122. doi: 10.1093/nar/gky1260.
4
Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2'-modifications and enhances antisense activity.热休克蛋白90(Hsp90)与含有疏水性2'-修饰的硫代磷酸酯寡核苷酸相互作用,并增强反义活性。
Nucleic Acids Res. 2016 May 5;44(8):3892-907. doi: 10.1093/nar/gkw144. Epub 2016 Mar 3.
5
Endosomal Escape of Antisense Oligonucleotides Internalized by Stabilin Receptors Is Regulated by Rab5C and EEA1 During Endosomal Maturation.稳定素受体内化的反义寡核苷酸的内涵体逃逸是由 Rab5C 和 EEA1 在内涵体成熟过程中调节的。
Nucleic Acid Ther. 2018 Apr;28(2):86-96. doi: 10.1089/nat.2017.0694. Epub 2018 Feb 13.
6
Chloroquine and cytosolic galectins affect endosomal escape of antisense oligonucleotides after Stabilin-mediated endocytosis.氯喹和胞质半乳糖凝集素在稳定素介导的内吞作用后影响反义寡核苷酸的内体逃逸。
Mol Ther Nucleic Acids. 2023 Jul 19;33:430-443. doi: 10.1016/j.omtn.2023.07.019. eCollection 2023 Sep 12.
7
Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index.对 PS-ASO 治疗药物进行化学修饰可降低细胞内蛋白质结合,提高治疗指数。
Nat Biotechnol. 2019 Jun;37(6):640-650. doi: 10.1038/s41587-019-0106-2. Epub 2019 Apr 29.
8
Origins of the Increased Affinity of Phosphorothioate-Modified Therapeutic Nucleic Acids for Proteins.硫代磷酸酯修饰的治疗性核酸与蛋白质亲和力增加的起源。
J Am Chem Soc. 2020 Apr 22;142(16):7456-7468. doi: 10.1021/jacs.9b13524. Epub 2020 Apr 10.
9
Phosphorothioate modified oligonucleotide-protein interactions.硫代磷酸酯修饰的寡核苷酸-蛋白质相互作用。
Nucleic Acids Res. 2020 Jun 4;48(10):5235-5253. doi: 10.1093/nar/gkaa299.
10
The conserved histidine in epidermal growth factor-like domains of stabilin-2 modulates pH-dependent recognition of phosphatidylserine in apoptotic cells.稳定素-2 的表皮生长因子样结构域中的保守组氨酸残基调节凋亡细胞中磷脂酰丝氨酸的 pH 依赖性识别。
Int J Biochem Cell Biol. 2010 Jul;42(7):1154-63. doi: 10.1016/j.biocel.2010.03.024. Epub 2010 Apr 9.

引用本文的文献

1
Structure-Activity Relationship of Antibody-Oligonucleotide Conjugates: Evaluating Bioconjugation Strategies for Antibody-siRNA Conjugates for Drug Development.抗体-寡核苷酸缀合物的结构-活性关系:评估用于药物开发的抗体-siRNA 缀合物的生物缀合策略。
J Med Chem. 2024 Sep 12;67(17):14852-14867. doi: 10.1021/acs.jmedchem.4c00802. Epub 2024 Aug 28.
2
Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes.动脉粥样硬化与炎症:通论病理过程学说的启示。
Int J Mol Sci. 2023 Apr 26;24(9):7910. doi: 10.3390/ijms24097910.
3
Drug Discovery Perspectives of Antisense Oligonucleotides.

本文引用的文献

1
Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs.反义寡核苷酸和双链 RNA 的化学、机制和临床状况。
Nucleic Acids Res. 2018 Feb 28;46(4):1584-1600. doi: 10.1093/nar/gkx1239.
2
Cellular uptake and trafficking of antisense oligonucleotides.反义寡核苷酸的细胞摄取和转运。
Nat Biotechnol. 2017 Mar;35(3):230-237. doi: 10.1038/nbt.3779. Epub 2017 Feb 27.
3
Characterizing the effect of GalNAc and phosphorothioate backbone on binding of antisense oligonucleotides to the asialoglycoprotein receptor.
反义寡核苷酸的药物发现前景
Biomol Ther (Seoul). 2023 May 1;31(3):241-252. doi: 10.4062/biomolther.2023.001. Epub 2023 Mar 2.
4
Inflammation: A New Look at an Old Problem.炎症:老问题的新视角。
Int J Mol Sci. 2022 Apr 21;23(9):4596. doi: 10.3390/ijms23094596.
5
Understanding In Vivo Fate of Nucleic Acid and Gene Medicines for the Rational Design of Drugs.了解核酸和基因药物的体内命运以进行药物的合理设计。
Pharmaceutics. 2021 Jan 26;13(2):159. doi: 10.3390/pharmaceutics13020159.
6
Transcriptional and functional insights into the host immune response against the emerging fungal pathogen Candida auris.转录和功能分析揭示宿主对新兴真菌病原体耳念珠菌的免疫反应。
Nat Microbiol. 2020 Dec;5(12):1516-1531. doi: 10.1038/s41564-020-0780-3. Epub 2020 Aug 24.
7
Role of the Hyaluronan Receptor, Stabilin-2/HARE, in Health and Disease.透明质酸受体 Stabilin-2/HARE 在健康和疾病中的作用。
Int J Mol Sci. 2020 May 15;21(10):3504. doi: 10.3390/ijms21103504.
8
Phosphorothioate modified oligonucleotide-protein interactions.硫代磷酸酯修饰的寡核苷酸-蛋白质相互作用。
Nucleic Acids Res. 2020 Jun 4;48(10):5235-5253. doi: 10.1093/nar/gkaa299.
9
Discovery of the Liver Hyaluronan Receptor for Endocytosis (HARE) and Its Progressive Emergence as the Multi-Ligand Scavenger Receptor Stabilin-2.内吞作用的肝透明质酸受体(HARE)的发现及其作为多配体清除受体稳定素-2的逐渐出现。
Biomolecules. 2019 Sep 6;9(9):454. doi: 10.3390/biom9090454.
10
Ligand Binding and Signaling of HARE/Stabilin-2.HARE/Stabilin-2 的配体结合和信号转导。
Biomolecules. 2019 Jul 11;9(7):273. doi: 10.3390/biom9070273.
表征N-乙酰半乳糖胺和硫代磷酸酯主链对反义寡核苷酸与去唾液酸糖蛋白受体结合的影响。
Nucleic Acids Res. 2017 Mar 17;45(5):2294-2306. doi: 10.1093/nar/gkx060.
4
Development of a Quantitative BRET Affinity Assay for Nucleic Acid-Protein Interactions.用于核酸-蛋白质相互作用的定量生物发光共振能量转移亲和力测定法的开发。
PLoS One. 2016 Aug 29;11(8):e0161930. doi: 10.1371/journal.pone.0161930. eCollection 2016.
5
The Medicinal Chemistry of Therapeutic Oligonucleotides.治疗性寡核苷酸的药物化学。
J Med Chem. 2016 Nov 10;59(21):9645-9667. doi: 10.1021/acs.jmedchem.6b00551. Epub 2016 Jul 29.
6
Stabilin-2 modulates the efficiency of myoblast fusion during myogenic differentiation and muscle regeneration.Stabilin-2在成肌分化和肌肉再生过程中调节成肌细胞融合的效率。
Nat Commun. 2016 Mar 14;7:10871. doi: 10.1038/ncomms10871.
7
Stabilin-1 and Stabilin-2 are specific receptors for the cellular internalization of phosphorothioate-modified antisense oligonucleotides (ASOs) in the liver.Stabilin-1和Stabilin-2是硫代磷酸酯修饰的反义寡核苷酸(ASO)在肝脏中进行细胞内化的特异性受体。
Nucleic Acids Res. 2016 Apr 7;44(6):2782-94. doi: 10.1093/nar/gkw112. Epub 2016 Feb 22.
8
Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides.反义寡核苷酸的药代动力学、生物分布和细胞摄取。
Adv Drug Deliv Rev. 2015 Jun 29;87:46-51. doi: 10.1016/j.addr.2015.01.008. Epub 2015 Feb 7.
9
Phosphorothioates, essential components of therapeutic oligonucleotides.硫代磷酸酯,治疗性寡核苷酸的重要组成部分。
Nucleic Acid Ther. 2014 Dec;24(6):374-87. doi: 10.1089/nat.2014.0506.
10
Probing structural selectivity of synthetic heparin binding to Stabilin protein receptors.探究合成肝素与 Stabilin 蛋白受体结合的结构选择性。
J Biol Chem. 2012 Jun 15;287(25):20774-83. doi: 10.1074/jbc.M111.320069. Epub 2012 Apr 30.